India has launched its first government-supported national biobank dedicated to Lysosomal Storage Disorders (LSDs), integrating clinical and genetic data from 530 patients across 15 states. Funded by the Department of Biotechnology, the initiative aims to develop affordable screening tools and therapies for rare genetic diseases.
The project is led by the Foundation for Research in Genetics and Endocrinology in Ahmedabad and covers 27 disorders under 8 LSD subgroups. The centralized digital biobank supports advanced research collaborations, including stem cell–based disease modeling and new diagnostic technologies. It is expected to significantly improve early detection and treatment accessibility for affected children.
